Charles Macri
Uniformed Services University of the Health Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles Macri.
Endocrinology | 1997
Alfredo Martínez; Theodore H. Elsasser; Carlos Muro-Cacho; Terry W. Moody; Mae Jean Miller; Charles Macri; Frank Cuttitta
Adrenomedullin (AM) is a multifunctional peptide involved in a variety of physiological functions, including growth regulation and antimicrobial activity. We have determined by immunohistochemistry and in situ hybridization that AM and its receptor are present in all the epithelial cells of the normal skin, including keratinocytes of the epidermis and hair follicles, as well as cells of the glands and secretory ducts. We also have detected AM in the sweat, by RIA. In addition, AM and its receptor were found in skin tumors of different histologies. The presence of AM and its receptor in normal and neoplastic skin was confirmed by RT-PCR and Western blot analysis performed on cell extracts from human skin cell lines. Radiolabeled AM bound to specific sites in cultured cells with a Kd of 9 nM. This binding was blocked by the addition of cold AM but not by related peptides such as AM 22-52, pro-AM 20 N-terminal peptide, calcitonin gene-related peptide, calcitonin gene-related peptide 8-37, or amylin. Finally, exposure to synthetic AM resulted in an increase of thymidine intake by skin cells. These results implicate AM as a potential player in skin defense against infectious microorganisms and as a possible autocrine growth factor in normal skin physiology and tumor development.
American Journal of Obstetrics and Gynecology | 1992
Charles Macri; David Schrimmer; Anna Leung; Jeffrey S. Greenspoon; Richard H. Paul
OBJECTIVE The null hypothesis is that the use of intrapartum amnioinfusion in labors complicated by the presence of thick meconium and oligohydramnios will not decrease the incidence of fetal distress, cesarean delivery, meconium aspiration, or meconium aspiration syndrome. STUDY DESIGN One hundred seventy term and postterm patients with thick meconium and oligohydramnios were randomly chosen to receive amnioinfusion or standard obstetric care without amnioinfusion. The frequency of fetal distress, cesarean section, meconium aspiration, and meconium aspiration syndrome were subject to chi 2 analysis, Students t test, or Fishers exact test. RESULTS The rate of fetal distress was significantly reduced in the amnioinfusion group compared with controls (three of 85 vs 19 of 85, relative risk 0.15, 95% confidence interval 0.06 to 0.42). The rate of cesarean section for fetal distress was significantly reduced in the amnioinfusion group (two of 85 vs 17 of 85, relative risk 0.118, confidence interval 0.03 to 0.49). The rates of meconium aspiration (four of 85 vs 33 of 85, relative risk 0.12, confidence interval 0.0449 to 0.327) and meconium aspiration syndrome (0 of 85 vs five of 85, relative risk 0.09, confidence interval 0.009 to 0.872) were significantly reduced by amnioinfusion. CONCLUSIONS Amnioinfusion improves the outcome in pregnancies complicated by thick meconium and oligohydramnios.
American Journal of Obstetrics and Gynecology | 1996
Charles Macri; Alfredo Martínez; Terry W. Moody; Karen Gray; Mae-Jean Miller; Michael W. Gallagher; Frank Cuttitta
OBJECTIVE Our purpose was to determine whether adrenomedullin, a multifunctional regulatory peptide involved in blood flow regulation and growth stimulation and with antimicrobial activity, was a component of amniotic fluid from second-trimester human fetus and to determine the source of this peptide. STUDY DESIGN A prospective descriptive study was performed on 134 patients undergoing amniocentesis after genetic counseling, ultrasonography, and informed consent. Adrenomedullin expression was determined by immunocytochemical analysis, Western blot analysis, reverse transcriptase-polymerase chain reaction, and in situ reverse transcriptase-polymerase chain reaction in fetal membranes and with radioimmunoassay in amniotic fluids. RESULTS Radioimmunoassay of the 134 amniotic fluid specimens revealed adrenomedullin-like immunoreactivity in all of them, ranging in concentration from 10 to 300 fmol/25 microliters (170 +/- 62 fmol/25 microliters). Immunocytochemical analysis, Western blot analysis, reverse transcriptase-polymerase chain reaction, and in situ reverse transcriptase-polymerase chain reaction further established the expression of adrenomedullin protein and messenger ribonucleic acid in fetal amniotic membranes, suggesting that this organ is the source of amniotic adrenomedullin. CONCLUSIONS Our results clearly demonstrate the presence of adrenomedullin in second-trimester human amniotic fluid and adrenomedullin messenger ribonucleic acid and protein in amniotic membranes, suggesting that adrenomedullin is a hormone involved in the maintenance of normal pregnancy. Further studies with these molecular tools are in progress to determine the precise role of this hormone and whether adrenomedullin plays a role in the pathogenesis of various disorders of pregnancy.
Peptides | 1999
Alfredo Martínez; T.H. Elsasser; Sam J. Bhathena; Ruben Pio; T.A Buchanan; Charles Macri; Frank Cuttitta
The study of two populations with a recent onset of type 2 diabetes showed that a subset of the patients had higher levels of adrenomedullin (AM) than the rest of the diabetics. In this subset, physiological elevations of AM might have triggered the disease in predisposed individuals. Diabetics showed higher levels of AM than healthy controls. In addition, glycemia was measured in diabetic rats after injection of saline, AM, or antiAM antibody. AM elevated glycemia, whereas the antibody reduced circulating glucose to normal. These results suggest that manipulation of AM levels could represent a new approach in the management of diabetes for the appropriate individuals.
Molecular Carcinogenesis | 1997
John H. Farley; Davonne Loup; Myra Nelson; Annette Mitchell; Gretchen Esplund; Charles Macri; Charles Harrison; Karen Gray
The incidence of cervical adenocarcinomas in young women over the last two decades has increased. Even with increasing knowledge of the role of human papillomavirus in the etiology of adenocarcinoma of the cervix, there is a paucity of data concerning the genetic and epigenetic factors that contribute to the histologic features and biologic behaviors of these tumors. Lactoferrin is a basic glycoprotein found in human milk, secondary granules of neutrophils, and many body secretions, and it has been associated with carcinogenesis of the endometrium, breast, and lymphoid systems. In this study, we examined the expression of lactoferrin in normal human endocervical epithelium and in cervical adenocarcinomas in relation to proliferative index, steroid receptor status, p53 protein expression, and apoptosis. Immunohistochemical and in situ studies demonstrated that lactoferrin protein and mRNA were strikingly downregulated upon neoplastic transformation of the endocervix as early as in adenocarcinoma in situ when compared with the prominent expression exhibited by the normal cervical epithelium. Furthermore, neoplastic transformation of endocervical epithelial cells was accompanied by a pronounced stimulation of proliferation and a substantial reduction in the expression of the estrogen and progesterone receptors and p53 but little or no change in the number of apoptotic cells. In conclusion, we identified lactoferrin as a novel cancer‐specific marker of endocervical adenocarcinomas that may be useful in the early detection of the disease, prediction of prognosis, and the development of new therapeutic modalities. Mol. Carcinog. 20:240–250, 1997.
Obstetrics and Gynaecology Cases - Reviews | 2015
Kathy Chyjek; Catherine Hutz; Charles Macri; Jeffrey S. Berger; Anthony C. Venbrux; Nadia J. Khati; Dorothy I. Bulas; John W. Larsen
C l i n M e d International Library Citation: Chyjek K, Hutz C, Macri C, Berger J, Venbrux A, et al. (2015) Cervical Varices Presenting as Vaginal Bleeding: A Description of Two Cases and A Management Plan. Obstet Gynecol Cases Rev 2:053 Received: April 20, 2015: Accepted: July 28, 2015: Published: August 01, 2015 Copyright:
Military Medicine | 2002
Stuart H Shippey; Jason O. Heaton; Charles Macri; Christian Macedonia
American Journal of Obstetrics and Gynecology | 1997
Charles Macri; Mae-Jean Miller; Karen Gray; Michael W. Gallagher; Alfredo Martínez; Frank Cuttitta
Obstetrics & Gynecology | 2018
Homa Ahmadzia; Susanne L. Bathgate; Charles Macri; Kate Denny; Scott Quinlan; Alexis C. Gimovsky
Obstetrics & Gynecology | 2018
Muhammed F. Shand; Alexis C. Gimovsky; Charles Macri